Featured Article

NIKE Pricing Spineometer: 2 of 5 Vertebrae

By Tim J. Smith, PhD December 31, 2025

NIKE, an athletic footwear, apparel, and equipment company selling NIKE, Jordan, and Converse brands, had a negative FY 2025. Revenue fell 9.8% to $46.3 billion, and earnings before interest and taxes fell 41% to $3.7 billion over last year. A review of NIKE’s 26 June 2025 earnings call and associated annual report provided insight regarding the importance of pricing on performance. FACTS FROM EARNINGS CALL AND ANNUAL REPORT FY 2025 has not…

Read More

In This Issue

Moderna Pricing Spineometer: 3 of 5 Vertebrae

By Tim J. Smith, PhD November 7, 2025

Moderna, a leader in mRNA medicine best known for its COVID vaccine, had a mixed FY 2024. Revenue fell 53% to $3.2…

Read More

Where and When is the Inflationary Impact of Tariffs?

By Tim J. Smith, PhD October 1, 2025

Tariffs are in the news, but will they have no to little impact on inflation? What can we expect in the next…

Read More

Bristol-Myers Squibb Pricing Spineometer: 4 of 5 Vertebrae

By Tim J. Smith, PhD October 1, 2025

Bristol-Myers Squibb, a global biopharmaceutical company, had a mixed FY 2024. Revenue rose 7.3% to $48.3 billion while operating earnings fell 199%…

Read More

Regeneron Pricing Spineometer: 3 of 5 Vertebrae

By Tim J. Smith, PhD October 1, 2025

Regeneron, a biotechnology company, had a mixed FY 2024. Revenue rose 8.3% to $14.2 billion, while operating profit fell 3.6% to $4.0…

Read More

WIGLAF, STRAIGHT
TO YOUR INBOX